Response on letter by Arya et al.: "evaluation of immune responses to an oral typhoid vaccine, Ty21a, in children from 2 to 5 years of age in Bangladesh."

Affiliations

¹ Centre for Vaccine Sciences, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.
² Centre for Vaccine Sciences, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh. Electronic address: fqadri@icddrb.org.
³ Department of Microbiology and Immunology, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden.
⁴ Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Comment

Taufiqur R Bhuiyan et al. Vaccine. 2014.

. 2014 Jul 7;32(32):4014.

doi: 10.1016/j.vaccine.2014.03.099. Epub 2014 May 14.

¹ Centre for Vaccine Sciences, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.
² Centre for Vaccine Sciences, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh. Electronic address: fqadri@icddrb.org.
³ Department of Microbiology and Immunology, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden.
⁴ Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

No abstract available

Comment on

Evaluation of immune responses to an oral typhoid vaccine, Ty21a, in children from 2 to 5 years of age in Bangladesh.
Bhuiyan TR, Choudhury FK, Khanam F, Saha A, Sayeed MA, Salma U, Lundgren A, Sack DA, Svennerholm AM, Qadri F. Bhuiyan TR, et al. Vaccine. 2014 Feb 19;32(9):1055-60. doi: 10.1016/j.vaccine.2014.01.001. Epub 2014 Jan 15. Vaccine. 2014. PMID: 24440210 Clinical Trial.
Comment on: evaluation of immune responses to an oral typhoid vaccine, Ty21a, in children from 2 to 5 years of age in Bangladesh.
Arya SC, Agarwal N. Arya SC, et al. Vaccine. 2014 Jul 7;32(32):4013. doi: 10.1016/j.vaccine.2014.04.071. Epub 2014 May 13. Vaccine. 2014. PMID: 24831232 No abstract available.